AMR in the environment: From monitoring to action
Online discussion hosted by the MEP Interest Group on AMR

13 November 2020

11:00-12:00 CET


The first of three online discussions in the run up to European Antibiotic Awareness Day hosted by the MEP Interest Group on AMR to raise awareness of the need for action, and find evidence-informed policy solutions to this urgent threat to human, animal and environmental health.

Take part in the debate and discuss what can can be done to boost actions to tackle AMR at EU level.


Pharmaceutical pollution is a global threat to ecosystems and human health. 771 different pharmaceutical substances have been detected in the environment across the world to date. As global consumption of human and veterinary medicines increases, this problem will only get worse. 

UN Environment has identified growing AMR linked to the discharge of antimicrobials into the environment as one of the most worrying health threats today. As wastewater treatment plants have limited capacities to remove antimicrobial residues, the role of the environment as a reservoir for AMR is particularly concerning.

Last year, the European Commission released a Strategic Approach to mitigate the impact of pharmaceutical pollution. In September, the Parliament adopted a strong resolution calling for bolder action with clear recommendations, including on antimicrobial residues that can act as a driver for AMR development in the environment.

The panelists discussed how the upcoming EU Pharmaceutical Strategy could address the environmental implications of production, use and disposal of antimicrobials, what could be done to achieve a zero-pollution ambition in relation to antimicrobial residues, and the lessons which could be learned from Member States to address environmental AMR.

Hosted by

Nicolae Ștefănuță MEP

Vice-Chair of the MEP Interest Group on Antimicrobial Resistance

Renew Europe, Romania



Yayoi Lagerqvist

Researcher and Co-Author of the report ‘The Health Paradox’


Nicolai Schaaf

Programme Manager

Stockholm International Water Institute (SIWI)

Caroline Moermond

Senior Advisor on Pharmaceuticals and the Environment

Dutch National Institute for Public Health and the Environment (RIVM)

Hans Stielstra

Deputy Head of Unit for Clean Water

European Commission

Moderated by

Jean-Yves Stenuick

Pharmaceuticals Policy & Projects Officer

Health Care Without Harm (HCWH) Europe


Join the MEP Interest Group on AMR also for:

Tackling the dependence of EU food systems on antimicrobials

16 November 2020

11:00-12:00 CET

Fixing the antibiotic innovation pipeline

17 November 2020

11:00-12:00 CET


Zoltán Massay-Kosubek

Policy Manager

European Public Health Alliance

Jean-Yves Stenuick

Pharmaceuticals Policy & Projects Officer

Health Care Without Harm (HCWH) Europe


HCWH Europe gratefully acknowledges the financial support of the European Commission (EC)’s LIFE programme. HCWH Europe is solely responsible for the content of this project and related materials. The views expressed do not reflect the official views of the EC.


Get involved !

Get involved !

Sign up here to receive our updates on European health policy and invitations to our events.

Subscribe now

You have Successfully Subscribed!

Share This